Novateor Research Laboratories Appoints Dental Expert Anil Tilakraj Arora as Independent Director

Novateor Research Laboratories Limited, a company listed on the Bombay Stock Exchange (BSE: 542771), has announced the appointment of Mr. Anil Tilakraj Arora as a Non-Executive Independent Director. The appointment, effective from September 3, 2025, was approved by shareholders at the company's 14th Annual General Meeting (AGM) held on September 30, 2025.

Appointment Details

Mr. Arora, who brings over four decades of experience as a dental practitioner and entrepreneur, has been appointed for a five-year term. His position will not be subject to retirement by rotation, in accordance with the provisions of sections 149 and 152 of the Companies Act, 2013.

Extensive Dental Expertise

With a career spanning more than 40 years, Mr. Arora has been a pioneer in India's dental community. His notable achievements include:

• Introducing India's largest private dental magazine
• Hosting the largest private dental exhibitions
• Running the largest network of private dental workshops

Mr. Arora's expertise extends to international dental conferences and involvement with boards of dental companies, making him a valuable addition to Novateor Research Laboratories' leadership.

Board Independence

The company has disclosed that Mr. Arora has no relationships with other board members, ensuring his independence in the role. This appointment aligns with corporate governance best practices, which emphasize the importance of independent oversight.

AGM Proceedings

The appointment was one of several items addressed during Novateor's AGM. Other key points from the meeting included:

• Adoption of financial statements for the year ended March 31, 2025
• Reappointment of Mr. Jitin Jaysukh Doshi as a director
• Authorization for related party transactions
• Approval for additions to the company's Memorandum of Association

Trading Window Closure

Following the AGM, Novateor Research Laboratories has announced the closure of its trading window for insiders, effective October 1, 2025. The window will reopen 48 hours after the announcement of the financial results for the half-year ending September 30, 2025.

This strategic appointment and the decisions made at the AGM reflect Novateor Research Laboratories' commitment to strengthening its governance and leveraging industry expertise to drive future growth in the dental and research sectors.